Injectable use may increase women's odds of getting chlamydia or gonorrhea.
R
R
MacLean
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D015142:Baltimore / Q000453:epidemiology; D002584:Cervix Uteri / Q000473:pathology; D002690:Chlamydia Infections / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D003267:Contraception / Q000706:statistics & numerical data*; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D005260:Female; D006069:Gonorrhea / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D012749:Sexually Transmitted Diseases / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D002577:Uterine Cervical Diseases / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control
D003278:Contraceptives, Oral, Hormonal; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate